Medicaid Gives New Protections to Beneficiaries in Managed Care Plans

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 8
Volume 11
Issue 8

WASHINGTON-Final regulations issued by the Department of Health and Human Services guarantee Medicaid beneficiaries enrolled in managed care plans the same protections granted to people in private plans under legislation pending

WASHINGTON—Final regulations issued by the Department of Health and Human Services guarantee Medicaid beneficiaries enrolled in managed care plans the same protections granted to people in private plans under legislation pending in Congress. The regulations take effect Aug. 13, and states and health plans have 1 year to come into full compliance. 

The rules guarantee emergency room care, a second opinion when needed, and a timely right to appeal decisions. However, each state will decide how to implement patient protection and use managed care in its Medicaid plan.

Recent Videos
Historical standards for H3 K27M-mutant diffuse midline glioma treatment may harm healthy central nervous system cells, according to Ashley L. Sumrall, MD.
2 experts are featured in this series.
1 expert is featured in this series.
2 experts are featured in this series.
Dordaviprone was recommended at a dose of 625 mg orally once weekly for adults, and the recommended dosage is based on body weight for pediatric patients.
Extended follow-up for individuals with H3 K27M-mutated diffuse midline glioma may help explain the duration of response across patient subgroups.